GPC-1 is an important clinical biomarker involved in the process of cancer onset, and it can be used as an important indicator of disease prognoses, such as breast cancer, lung cancer, colorectal cancer, glioma, pancreatic cancer, and esophageal cancer [32]. This evidence concerns the gene GPC1 and central nervous system cancer.